Sibusiso, a 39-year-old HIV patient in Eswatini, faced uncertainty as the Trump administration paused PEPFAR, a vital AIDS relief program in Africa. The abrupt halt caused clinic closures, medication shortages, and fears of a return to the HIV epidemic’s darkest days. With staff shortages and treatment delays, lives were at risk as patients struggled to access essential medications and care.
Full Article
Loading PerspectiveSplit analysis...






